Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 429 participants.

Also called NCT06696820

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 429 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06696820
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06696820. Randomized; single masking; primary purpose treatment. Start 2024-11-29 (actual); primary completion 2026-03-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke
Acronym
CAPTAIN
Condition
Acute Ischemic Stroke
Intervention (Drug)
PCSK9 inhibitors combined with atorvastatin/rosuvastatin
Intervention (Drug)
Atorvastatin/Rosuvastatin
Lead sponsor
Xiang Luo (class: other)
Collaborator
The Third People's Hospital of Hubei Province (class: other)
Collaborator
Yichang Central People's Hospital (class: other)
Collaborator
The Fifth Hospital of Wuhan (class: other)
Collaborator
Shanghai Zhongshan Hospital (class: other)
Collaborator
Renmin Hospital of Wuhan University (class: other)
Collaborator
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (class: other)
Collaborator
Wuhan Third Hospital (class: other)
Collaborator
Taihe Hospital (class: other)
Collaborator
Tianyou Hospital Affiliated to Wuhan University of Science and Technology (class: other)
Collaborator
Santai People's Hospital (class: not stated)
Collaborator
The General Hospital of Central Theater Command (class: other)
Collaborator
Minda Hospital of Hubei Minzu University (class: not stated)
Collaborator
Hubei Shiyan People's Hospital (class: not stated)
Collaborator
Zigong Fourth People's Hospital (class: not stated)
Collaborator
Wuhan No.1 Hospital (class: other)
Collaborator
Hanyang Hospital Affiliated to Wuhan University of Science and Technology (class: other)
Collaborator
Changjiang Shipping General Hospital (class: not stated)
Collaborator
Wuhan NO. 4 hospital (class: not stated)
Collaborator
Affiliated Renhe Hospital of China Three Gorges University, China (class: not stated)
Collaborator
Wuhan Central Hospital (class: other)
Collaborator
Nanyang Central Hospital (class: other)
Collaborator
Yichang Yiling Hospital (class: not stated)
Collaborator
Mianyang Central Hospital (class: other)
Collaborator
Xihua First Hospital (class: other)
Collaborator
Neijiang No.2 People's Hospital (class: other)
Collaborator
The Central Hospital of Huanggang (class: other)
Collaborator
The Tirst People's Hospital of Mianyang (class: not stated)
Collaborator
People's Hospital of Dangyang (class: other)
Collaborator
Chengdu Jingdongfang Hospital (class: not stated)
Collaborator
Wuhan Hankou Hospital (class: not stated)
Collaborator
Zhongxiang Traditional Chinese Medicine (TCM) Hospital (class: not stated)
Collaborator
Sichuan Science City Hospital (class: not stated)
Collaborator
The People's Hospital of Huangpi (class: not stated)
Collaborator
Ba Zhong Shi Zhong Yi Yi Yuan (class: not stated)
Collaborator
Beichuan Qiang Autonomous County People's Hospital (class: not stated)
Collaborator
The First People's Hospital of Mianyang (class: not stated)

Registry records

Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry organizations 15

Record details

Record id
cardio:ct-nct06696820
Content hash
ccfd56d1e5c0c32db4eea73e975745c3762256bee7497343e50e58717d14c474